A somatostatin-secreting tumor, or somatostatinoma, should always be suspected in the presence of signs and symptoms associated with somatostatin excess: The most common clinical features are diabetes mellitus, diarrhea, and cholelithiasis, but weight loss and hypochlorhydria could also be associated with the elevated serum somatostatin levels. This evidence concerns the gene SST and neoplasm.